INS and congestive heart failure: Table 2 quantifies exposure time to analogue or human insulin and the number of events for each of the 5 outcomes. Overall, participants experienced 5464 deaths (4.3%), 1729 MIs (1.4%), 1301 CVAs (1.0%), and 3082 CHF hospitalizations (2.4%). Table 2 also displays distribution of reasons for end of follow-up in all primary analyses.